Business Context and Reporting Period
This Form 6-K filing by Anbio Biotechnology, a foreign private issuer based in Frankfurt am Main, Germany, covers the month of November 2025. The report specifically addresses a change in the Company's independent registered public accounting firm.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding corporate governance and audit firm changes rather than a financial results announcement.
Material Changes
- Termination of Previous Auditor: Effective November 10, 2025, the Company terminated YCM CPA INC. as its independent registered public accounting firm.
- Appointment of New Auditor: On November 10, 2025, the Board of Directors and Audit Committee approved and ratified the appointment of HTL International, LLC as the new independent registered public accounting firm.
- Audit History: Reports issued by YCM CPA INC. for fiscal years ended December 31, 2024, 2023, and 2022 did not contain adverse opinions, disclaimers, or qualifications regarding uncertainty, audit scope, or accounting principles.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary on business operations. Regarding risks and contingencies, the Company stated there were no disagreements with the former auditor (YCM CPA INC.) on accounting principles, practices, or auditing scope during the most recent fiscal year or through the date of dismissal. Additionally, no "reportable events" as defined in Regulation S-K occurred. The Company confirmed it has not consulted the new auditor (HTL International, LLC) on any accounting or auditing matters prior to their engagement.
Investor Verification Checklist
- Verify the effective date of the auditor change (November 10, 2025).
- Confirm the identity of the new auditor (HTL International, LLC) and the former auditor (YCM CPA INC.).
- Review the attached Exhibit 16.1 (Letter from YCM CPA INC.) to ensure the former auditor agrees with the Company's statements regarding the dismissal.
- Check for any future filings that may disclose the rationale for the change if not explicitly detailed in this summary.